Melarsoprol is a member of triazines. Melarsoprol is under investigation in clinical trial NCT00330148 (Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis). Arsenical used in trypanosomiases. It may cause fatal encephalopathy and other undesirable side effects. It is grouped under the following drug class(es): Trypanosomiasis agents. Its therapeutic use is listed as antiparasitics and antiprotozoals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Mel B and Melarsoprolum. Its PubChem CID is 10311.
Melarsoprol
| CAS No | 494-79-1 |
|---|---|
| Molecular Formula | C12H15AsN6OS2 |
| Molecular Weight | 398.3 g/mol |
| Synonyms | [2-[4-[(4,6-diamino-1,3,5-triazin-2-yl)amino]phenyl]-1,3,2-dithiarsolan-4-yl]methanol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Melarsoprol is a member of triazines. Melarsoprol is under investigation in clinical trial NCT00330148 (Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis).
The listed CAS number is 494-79-1.
The listed molecular formula is C12H15AsN6OS2.
The listed molecular weight is 398.3 g/mol.
[2-[4-[(4,6-diamino-1,3,5-triazin-2-yl)amino]phenyl]-1,3,2-dithiarsolan-4-yl]methanol.
The source lists Mel B and Melarsoprolum.